Hi, I am Marmee Regine, your host in Pandemic Podcast Coronavirus. Today is a special episode where we will listen to a discussion on the Covid-19 variant called Omicron. Early this year, I published an episode on this podcast about the vaccine and variant, which I later turned into an eBook on the Amazon website. So, I believe we have to listen to an Omicron study that the good doctor, Dr. John Campbell discusses. Last May 9, 2021, in a special episode of this podcast, Dr. Campbell discussed Ivermectin prophylactic study from India. In the recently released video of Dr. Campbell, he captioned Omicron as the worst ever Covid variant. I believed in his expert opinion, for he has a million subscribers on his channel. Let me read some of the background information of the study that Dr. Campbell released online. 
Worst ever Covid variant? Omicron B.1.1.529  - Features: Increased contagion, Immune escape, Sicker people, WHO, VOC – aka variant of concern
https://www.who.int/news/item/26-11-2... In the article, "The Technical Advisory Group on SARS-CoV-2 Virus Evolution Independent group of experts". First reported to WHO from South Africa on November 24021 South Africa, where infections have increased steeply, coinciding with the detection of B.1.1.529 variant. The first known confirmed B.1.1.529 infection was from a specimen collected on November 91. Preliminary evidence suggests an increased risk of reinfection with this variant. The number of cases of this variant appears to be increasing in almost all provinces in South Africa Current SARS-CoV-2 PCR diagnostics continue to detect this variant. For one widely used PCR test, one of the three target genes is not detected (called S gene dropout or S gene target failure). This variant may have a growth advantage. The ARTICLE that Dr. Campbell reads as follows: The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behavior of the virus. The TAG-VE was convened on NoveNovember 261 to assess the SARS-CoV-2 variant: B.1.1.529. The B.1.1.529 variant was first reported to WHO from South Africa on NoveNovember 241.   The epidemiological situation in South Africa has been characterized by three distinct peaks in reported cases, the latest of which was predominantly the Delta variant. In recent weeks, infections have increased steeply, coinciding with the detection of the B.1.1.529 variant. The first known confirmed B.1.1.529 infection was from a specimen collected on November 9, interesting; my birthday this year was November 10, November 10ontinue; this variant has a large number of mutations, some of which are concerning. Preliminary evidence suggests an increased risk of reinfection with this variant, as compared to other VOCs (a variant of concerns). The number of cases of this variant appears to be increasing in almost all provinces in South Africa. Current SARS-CoV-2 PCR diagnostics continue to detect this variant. Several labs have indicated that for one widely used PCR test, one of the three target genes is not detected (called S gene dropout or S gene target failure), and this test can therefore be used as a marker for this variant, pending sequencing confirmation. Using this approach, this variant has bee

Support the show (https://www.patreon.com/pandemicpodcastcoronavirus)